Medtronic Expands Ortho Biologics Presence With Osteotech Acquisition
This article was originally published in The Gray Sheet
Executive Summary
Medtronic is shoring up its orthopedic biologics business through the acquisition of demineralized bone matrix marketer Osteotech for $123 million, announced Aug. 17